MedPath

Effect of Non-Invasive Neuromodulation in improving balance and gait of individuals with Parkinson´s disease

Not Applicable
Conditions
Parkinson disease
C10.574
Registration Number
RBR-3mywq86
Lead Sponsor
niversidade Estadual de Londrina
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Data analysis completed
Sex
Not specified
Target Recruitment
Not specified
Inclusion Criteria

Medical diagnosis of Parkinson's disease according to the criteria of the London Brain Bank (Uk Parkinson's Disease Society Brain Bank Clinical Diagnostic Criteria); age range between 50 and 85 years; not institutionalized; mini-mental score that does not characterize cognitive impairment; Hoehn&Yahr scale between 1.5 and 3.0; which accept to participate of the project and sign the consent term according to the criteria of the Ethics Committee of the Universidade Estadual de Londrina, according to the parecer 466/2912 (National Health Council)

Exclusion Criteria

Individuals who perform another therapeutic treatment beyond medication; that has change in medication during the study; or those with associated diseases, such as neurological disorders, severe heart disease, amputations, cognitive or understanding deficits. Change in the stabilization of the antiparkinsonian medication doses throughout the study

Study & Design

Study Type
Intervention
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Gait is expected to improve evaluated in the gait laboratory through the following parameters: increase in step length, increase in gait speed and facilitation to overcome obstacle, that is, to overcome the obstacle without significant change in speed.<br>The gait laboratory is composed of 7 cameras, which capture all the patient&apos;s movements in 3D. The kinematic analysis of gait will be performed by filming the patient during the following activities: walking at normal speed, walking performing simple counts and overcoming obstacles while walking.;Postural balance is expected to improve assessed before and after the intervention by assessment performed in a gait laboratory, analyzing the following parameters: decrease in displacement and in anteroposterior and mediolateral amplitude of the center of mass, which means that the patient oscillated less. Patients will be evaluated with feet parallel and with one foot positioned in front of the other, in the condition of eyes open and eyes closed.
Secondary Outcome Measures
NameTimeMethod
o secondary outcomes are expected.
© Copyright 2025. All Rights Reserved by MedPath